---
title: 'Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study'
contributors: 'Leung BW, Wan G, Nguyen N, Rashdan H, Zhang S, Chen W, Cohen S, Boland GM, Sullivan RJ, Fadden RM, Kaufman HL, Kwatra SG, LeBoeuf NR, Semenov YR.(2023).'
publication: Journal of the American Academy of Dermatology, 88(6):1265-1270
publication_link: https://doi.org/10.1016/j.jaad.2023.02.017

image: publications/increased-risk-of-cutaneous-immune-related-adverse-events-in-patients-treated-with-talimogene-laherparepvec-and-immune-checkpoint-inhibitors.jpg

group: profiling

date: 2023-06-01

minerva_link:
pubmed_link: https://pubmed.ncbi.nlm.nih.gov/36944564/
dataset_link:
preprint_link:
pdf_link:
show_page_link: false
tags:
    - MEL
---
